Tenders of Kkh Kaufm Nnische Krankenkasse
Tenders of Kkh Kaufm Nnische Krankenkasse
KKH Kaufm Nnische Krankenkasse - KKH Tender
Chemical Products
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents
Conclusion of non-exclusive discount agreements according to § 130a paragraph 8 Sgb V to the in II.2.4. Mentioned active ingredients with the possibility of closing within the framework of the so-called open-house procedure. (2023-26407-oh- emtricitabine, tenofovir disoproxil and rilpiviri
KKH Kaufm Nnische Krankenkasse - KKH Tender
Chemical Products
Germany
Closing Date31 Jul 2025
Tender AmountRefer Documents
Conclusion of non-exclusive discount agreements according to § 130a paragraph 8 Sgb V to the in II.2.4. Mentioned active ingredients with the possibility of completion within the framework of the so-called open-house procedure. (2023-27271-ohb-clobetasol-17-propionate cream, ointment, fatty ointment
KKH Kaufm Nnische Krankenkasse - KKH Tender
Others
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents
Completion of non-exclusive discounts according to § 130a para. 8 Sgb V To The In Ii.2.4. Known active ingredients With the possibility of completing the so-called open-house process. (2023-22921_methoxy-polyethylene glycol epoetin Beta)
KKH Kaufm Nnische Krankenkasse - KKH Tender
Healthcare and Medicine
Germany
Closing Date31 Dec 2026
Tender AmountRefer Documents
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130a Abs. 8 Sgb V Zu Den Genannten Wirkstoffen Mit Abschlussmöglichkeit Im Rahmen Des Sogenannten Open-house-verfahrens.
KKH Kaufm Nnische Krankenkasse - KKH Tender
Chemical Products
Germany
Closing Date31 Oct 2025
Tender AmountRefer Documents
Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V to those in Ii.2.4. The active ingredients mentioned with the possibility of contracting within the framework of the so-called open-house procedure. (2023-26435-oh-pasireotide)
211-220 of 247 active Tenders